145 related articles for article (PubMed ID: 16688961)
1. [A case of follicular lymphoma of the duodenum treated with the combined therapy of anti-CD20 antibody and chemotherapy].
Isogai K; Yamamoto E; Yamaoka S; Tarasawa I; Murakami R; Morimoto I; Obata T; Mori M; Endo T; Imai K
Nihon Shokakibyo Gakkai Zasshi; 2006 Mar; 103(3):301-9. PubMed ID: 16688961
[No Abstract] [Full Text] [Related]
2. Hematology: The case against rituximab maintenance.
Cheson BD
Nat Rev Clin Oncol; 2009 Nov; 6(11):622-4. PubMed ID: 19861992
[No Abstract] [Full Text] [Related]
3. [Antibody therapy in hematology and oncology - part 1].
Kneba M; Schrader C; Köhne H
Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
[No Abstract] [Full Text] [Related]
4. Use of rituximab in patients with follicular lymphoma.
Marcus R
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):38-49. PubMed ID: 17305253
[TBL] [Abstract][Full Text] [Related]
5. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
[No Abstract] [Full Text] [Related]
6. Clinical and molecular complete remission of primary duodenal follicular lymphoma following treatment with rituximab and cyclophosphamide, vincristine and prednisone chemotherapy.
Falorio S; Angrilli F; Fioritoni G
Intern Med J; 2009 Oct; 39(10):706-7. PubMed ID: 19849763
[No Abstract] [Full Text] [Related]
7. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
Barr PM
Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320
[No Abstract] [Full Text] [Related]
8. Hematology: Follicular lymphoma: maintenance therapy is (often) indicated.
Seymour JF
Nat Rev Clin Oncol; 2009 Nov; 6(11):624-6. PubMed ID: 19861993
[No Abstract] [Full Text] [Related]
9. Primary duodenal follicular lymphoma successfully treated with rituximab.
Aguiar-Bujanda D; Quiñones-Morales I; Camacho-Galán R; Llorca-Martínez I; Rivero-Vera JC; Bohn-Sarmiento U; Aguiar-Morales J
Clin Transl Oncol; 2007 Jul; 9(7):471-2. PubMed ID: 17652063
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
11. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.
Dakhil S; Hermann R; Schreeder MT; Gregory SA; Monte M; Windsor KS; Hurst D; Chai A; Brewster M; Richards P
Leuk Lymphoma; 2014 Oct; 55(10):2335-40. PubMed ID: 24471908
[TBL] [Abstract][Full Text] [Related]
12. Obstructive jaundice caused by primary duodenal lymphoma. Case report and review of the literature.
Peter U; Honegger H; Koelz HR
Digestion; 2007; 75(2-3):124-5. PubMed ID: 17630473
[No Abstract] [Full Text] [Related]
13. Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma.
Messori A; Fadda V; Maratea D; Trippoli S
Leuk Lymphoma; 2015; 56(9):2728-30. PubMed ID: 25651429
[No Abstract] [Full Text] [Related]
14. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Watanabe R; Tomita N; Kishimoto K; Koyama S; Ogusa E; Ishii Y; Miyashita K; Matsuura S; Fujisawa S; Hattori Y; Takasaki H; Fujita A; Ohshima R; Kuwabara H; Hashimoto C; Fujimaki K; Sakai R; Ishigatsubo Y
Leuk Res; 2013 Oct; 37(10):1208-12. PubMed ID: 23927994
[TBL] [Abstract][Full Text] [Related]
15. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
Gordon LI
Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
[No Abstract] [Full Text] [Related]
16. Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Provencio M; Cruz Mora MÁ; Gómez-Codina J; Quero Blanco C; Llanos M; García-Arroyo FR; de la Cruz L; Gumá Padró J; Delgado Pérez JR; Sánchez A; Alvarez Cabellos R; Rueda A;
Leuk Lymphoma; 2014 Jan; 55(1):51-5. PubMed ID: 23573825
[TBL] [Abstract][Full Text] [Related]
17. Meningeal relapse by follicular lymphoma as a single mass.
Moreno García V; Redondo A; Fernández Zubillaga A; González-Barón M
Clin Transl Oncol; 2008 Mar; 10(3):180-1. PubMed ID: 18321822
[TBL] [Abstract][Full Text] [Related]
18. Does monocyte count have prognostic significance in cancer?
Tadmor T
Leuk Res; 2013 Oct; 37(10):1193-4. PubMed ID: 23953915
[No Abstract] [Full Text] [Related]
19. [Synchronous cervical intraepithelial neoplasia and cervical follicular non-Hodgkin lymphoma: report of a case].
Zhu H; Xie JL; Yu R; Gong LP; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):841-2. PubMed ID: 20193463
[No Abstract] [Full Text] [Related]
20. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
Griffiths R; Gleeson M; Reyes C; Knopf K; Danese M
Am J Hematol; 2010 Dec; 85(12):963-7. PubMed ID: 20981680
[No Abstract] [Full Text] [Related]
[Next] [New Search]
